-o-
-lim-
reagin
ocrelizumab
idiospecific
heterophile antibody
atezolizumab
heterophil antibody
Forssman antibody
conatumumab
panitumumab
-ab
immunospecific
drozitumab
evolocumab
heterophile
bezlotoxumab
sulesomab
oleclumab
robatumumab
alloantibody
immunoprobe
biciromab
zolimomab
siltuximab
olendalizumab
Ab
bococizumab
onartuzumab
-a-
dacetuzumab
monoclonal
antiantibody
antigenic
pancytokeratin
iratumumab
intrabody
inotuzumab ozogamicin
antisynthetase
antigenomic
tabalumab
agonistic monoclonal antibody
countercorrelated
lintuzumab
matuzumab
-i-
brentuximab
ABO antibodies
polyantibody
immunonaive